Keymed Biosciences Inc. (HKG:2162)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
47.80
+1.85 (4.03%)
Jun 6, 2025, 4:08 PM HKT

Keymed Biosciences Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
13,1748,51613,58614,2679,651-
Upgrade
Market Cap Growth
-37.32%-37.32%-4.77%47.83%--
Upgrade
Enterprise Value
11,6826,55510,72510,42415,170-
Upgrade
Last Close Price
47.8030.9049.1051.0034.50-
Upgrade
PS Ratio
28.9218.6934.83126.1271.30-
Upgrade
PB Ratio
5.003.234.133.782.16-
Upgrade
P/TBV Ratio
5.023.254.133.782.15-
Upgrade
EV/Sales Ratio
25.6414.3927.4992.15112.08-
Upgrade
Debt / Equity Ratio
0.300.300.140.040.01-1.33
Upgrade
Asset Turnover
0.110.110.090.030.05-
Upgrade
Inventory Turnover
0.130.130.660.071.02-
Upgrade
Quick Ratio
3.043.048.808.4531.554.42
Upgrade
Current Ratio
3.303.309.368.7231.964.75
Upgrade
Return on Equity (ROE)
-18.85%-18.85%-11.31%-8.69%-305.24%-
Upgrade
Return on Assets (ROA)
-10.23%-10.23%-7.32%-8.65%-10.09%-15.67%
Upgrade
Return on Capital (ROIC)
-11.80%-11.80%-8.33%-9.52%-11.15%-20.89%
Upgrade
Earnings Yield
-4.16%-6.44%-2.91%-2.44%-49.44%-
Upgrade
FCF Yield
-8.06%-12.46%-5.53%-5.39%-4.92%-
Upgrade
Buyback Yield / Dilution
-0.22%-0.22%-0.09%-62.34%-139.72%-
Upgrade
Updated Sep 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.